For conjugation of palmitate (Sigma) with BSA (Sigma), 538.4 mg ultra-low fatty acid BSA was diluted in 12 mL autoclaved, 37 °C warm 150 mM NaCl, followed by incubation at 37 °C till BSA is dissolved. Then, 9.18 mg palmitate was diluted in 6.6 mL of warm 150 mM NaCl and then heated at 70 °C with stirring till the solution was clear. Thereafter, 8.25 mL warm BSA solution was transferred to a new tube and palmitate solution was added slowly to BSA solution. The conjugate of palmitate to BSA was stirred for 1 h at 37 °C. Then, 1.65 mL 150 mM NaCl solution was added to the conjugate and pH was adjusted to 7.4 with 1 M NaOH. The conjugate solution was aliquoted and stored at −20 °C. BSA vehicle was prepared by mixing 3 mL BSA solution with 3 mL 150 mM NaCl. BSA vehicle was aliquoted and stored at −20 °C. The molar ratio of conjugated palmitate:BSA was as 6:1. Prior cell treatment with palmitate:BSA conjugate, both BSA and palmitate were thawed at 37 °C for 10 min.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.